India · Delayed Price · Currency is INR Amerise Biosciences Statistics
Total Valuation
BOM:531681 has a market cap or net worth of INR 44.93 million. The enterprise value is 44.69 million.
| Market Cap | 44.93M |
| Enterprise Value | 44.69M |
Important Dates
The last earnings date was Monday, February 2, 2026.
| Earnings Date | Feb 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:531681 has 66.07 million shares outstanding.
| Current Share Class | 66.07M |
| Shares Outstanding | 66.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -49.65% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 7.22% |
| Float | 51.47M |
Valuation Ratios
The trailing PE ratio is 22.88.
| PE Ratio | 22.88 |
| Forward PE | n/a |
| PS Ratio | 12.34 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 70.60 |
| EV / Sales | 12.28 |
| EV / EBITDA | n/a |
| EV / EBIT | 68.23 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 1.20% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 3.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:531681 has paid 19,000 in taxes.
| Income Tax | 19,000 |
| Effective Tax Rate | 2.91% |
Stock Price Statistics
The stock price has decreased by -25.27% in the last 52 weeks. The beta is -0.13, so BOM:531681's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -25.27% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.71 |
| Relative Strength Index (RSI) | 54.06 |
| Average Volume (20 Days) | 149,616 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531681 had revenue of INR 3.64 million and earned 633,000 in profits. Earnings per share was 0.03.
| Revenue | 3.64M |
| Gross Profit | 3.64M |
| Operating Income | 655,000 |
| Pretax Income | 652,000 |
| Net Income | 633,000 |
| EBITDA | n/a |
| EBIT | 655,000 |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 237,000 in cash and n/a in debt, with a net cash position of 237,000 or 0.00 per share.
| Cash & Cash Equivalents | 237,000 |
| Total Debt | n/a |
| Net Cash | 237,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 53.29M |
| Book Value Per Share | 1.26 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 17.99% and 17.39%.
| Gross Margin | 100.00% |
| Operating Margin | 17.99% |
| Pretax Margin | 17.91% |
| Profit Margin | 17.39% |
| EBITDA Margin | n/a |
| EBIT Margin | 17.99% |
| FCF Margin | n/a |
Dividends & Yields
BOM:531681 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |